COVID-19 - International Biopharmaceutical Industry

Current Edition

news

US stocks up on COVID-19 antibody drugs amid shortage concerns

The antibody treatments from Regeneron and Eli Lilly have been proven effective in reducing the risk of hospitalization or death from COVID-19 in certain high-risk in...

17 September 2021 news Antibody | bamlanivimab

Continue Reading →

Volume 4 Issue 3

Shoring up Diagnostics Manufacturing for the Next Pandemic

As the global response to COVID-19 continues to move from a state of national lockdowns to the re-opening of societies, diagnostic assay developers are confronting tw...

1 September 2021 Volume 4 Issue 3 COVID-19 | Disease

Continue Reading →

news

Moderna says vaccine protective through six months, but warns boosters needed this fall

Like Pfizer, Moderna is pressing the case for booster shots, although public health officials and experts have not yet agreed on when an additional dose would be need...

13 August 2021 news boosters | coronavirus

Continue Reading →

news

A Roche arthritis drug fails in COVID-19, casting doubt on a strained hypothesis

Roche's anti-inflammatory drug Actemra did not help patients hospitalized with severe COVID-19-associated pneumonia, according to Phase 3 results announced by the Swi...